Evaluation of the pharmacokinetics–pharmacodynamics of fusidic acid against Staphylococcus aureus and Streptococcus pyogenes using in vitro infection models: implications for dose selection
- 1 May 2011
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 70 (1) , 101-111
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Impact of Burden on Granulocyte Clearance of Bacteria in a Mouse Thigh Infection ModelAntimicrobial Agents and Chemotherapy, 2010
- Spectrum of activity, mutation rates, synergistic interactions, and the effects of pH and serum proteins for fusidic acid (CEM-102)Diagnostic Microbiology and Infectious Disease, 2010
- Pharmacodynamics of Vancomycin at Simulated Epithelial Lining Fluid Concentrations against Methicillin-Resistant Staphylococcus aureus (MRSA): Implications for Dosing in MRSA PneumoniaAntimicrobial Agents and Chemotherapy, 2009
- Development and Qualification of a Pharmacodynamic Model for the Pronounced Inoculum Effect of Ceftazidime against Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2009
- Dumb and Dumber--The Potential Waste of a Useful Antistaphylococcal Agent: Emerging Fusidic Acid Resistance in Staphylococcus aureusClinical Infectious Diseases, 2006
- Use of Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Support Phase 2 and 3 Dosing Strategies for DoripenemAntimicrobial Agents and Chemotherapy, 2005
- Selection of a Moxifloxacin Dose That Suppresses Drug Resistance inMycobacterium tuberculosis,by Use of an In Vitro Pharmacodynamic Infection Model and Mathematical ModelingThe Journal of Infectious Diseases, 2004
- Use of Preclinical Data for Selection of a Phase II/III Dose for Evernimicin and Identification of a Preclinical MIC BreakpointAntimicrobial Agents and Chemotherapy, 2001
- In Vitro Activities of Daptomycin, Arbekacin, Vancomycin, and Gentamicin Alone and/or in Combination against Glycopeptide Intermediate-Resistant Staphylococcus aureus in an Infection ModelAntimicrobial Agents and Chemotherapy, 2000
- Kinetics and Mechanisms of Drug Action on Microorganisms XX: Integrated Receptor Site Model Rationalizing Observed Microbial Rate Dependencies on Drug Concentration and Microbial Kinetics Affected by Sodium FusidateJournal of Pharmaceutical Sciences, 1974